Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive field. Furthermore, he discusses the importance of open communication with gynaecologists and Gynial’s unique product philosophy as well as the company’s strategy to diversify their revenue streams through portfolio and international expansion.
What where the key motivations to open a company focused on women’s health?
"Our products are developed in cooperation with experts in the field and we take special care to select the best-proven treatments according to the authorities' recommendations."
